{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:14:31Z","timestamp":1793142871373,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ebiom.2022.104108","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T14:07:42Z","timestamp":1655906862000},"page":"104108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Targeting miR-30d reverses pathological cardiac hypertrophy"],"prefix":"10.1016","volume":"81","author":[{"given":"Jin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanru","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zitong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumya","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ebiom.2022.104108_bib0001","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"19","key":"10.1016\/j.ebiom.2022.104108_bib0002","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.3390\/ijms20194714","article-title":"MicroRNAs in cardiac hypertrophy","volume":"20","author":"Wehbe","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104108_bib0003","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.ymthe.2022.01.031","article-title":"miR-486 attenuates cardiac ischemia\/reperfusion injury and mediates the beneficial effect of exercise for myocardial protection","volume":"30","author":"Bei","year":"2022","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104108_bib0004","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s12265-021-10116-w","article-title":"Dickkopf 3: a novel target gene of miR-25-3p in promoting fibrosis-related gene expression in myocardial fibrosis","volume":"14","author":"Zeng","year":"2021","journal-title":"J Cardiovasc Transl Res"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104108_bib0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/nat.2020.0871","article-title":"Efficiency and target derepression of anti-miR-92a: results of a first in human study","volume":"30","author":"Abplanalp","year":"2020","journal-title":"Nucleic Acid Ther"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104108_bib0006","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehaa898","article-title":"Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study","volume":"42","author":"Taubel","year":"2021","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.ebiom.2022.104108_bib0007","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.114.013220","article-title":"Circulating MicroRNA-30d is associated with response to cardiac resynchronization therapy in heart failure and regulates cardiomyocyte apoptosis: a translational pilot study","volume":"131","author":"Melman","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104108_bib0008","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIRCRESAHA.120.317244","article-title":"Mir-30d regulates cardiac remodeling by intracellular and paracrine signaling","volume":"128","author":"Li","year":"2021","journal-title":"Circ Res"},{"issue":"14","key":"10.1016\/j.ebiom.2022.104108_bib0009","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.7150\/thno.46225","article-title":"The anti-microbial peptide LL-37\/CRAMP levels are associated with acute heart failure and can attenuate cardiac dysfunction in multiple preclinical models of heart failure","volume":"10","author":"Zhou","year":"2020","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104108_bib0010","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cmet.2015.02.014","article-title":"miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling","volume":"21","author":"Liu","year":"2015","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104108_bib0011","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ymthe.2020.12.002","article-title":"Inhibition of lncRNA MAAT controls multiple types of muscle atrophy by cis- and trans-regulatory actions","volume":"29","author":"Li","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.ebiom.2022.104108_bib0012","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.omtn.2020.12.015","article-title":"Angiotensin II-induced muscle atrophy via PPARgamma suppression is mediated by miR-29b","volume":"23","author":"Li","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104108_bib0013","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1159\/000459899","article-title":"Circulating miR-30d predicts survival in patients with acute heart failure","volume":"41","author":"Xiao","year":"2017","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104108_bib0014","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/HYPERTENSIONAHA.121.17574","article-title":"Percutaneous intracoronary delivery of plasma extracellular vesicles protects the myocardium against ischemia-reperfusion injury in canis","volume":"78","author":"Wang","year":"2021","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104108_bib0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.stem.2012.09.013","article-title":"Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes","volume":"12","author":"Tohyama","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104108_bib0016","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.ymthe.2022.01.031","article-title":"miR-486 attenuates cardiac ischemia\/reperfusion injury and mediates the beneficial effect of exercise for myocardial protection","volume":"30","author":"Bei","year":"2022","journal-title":"Mol Ther"},{"issue":"39","key":"10.1016\/j.ebiom.2022.104108_bib0017","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1038\/onc.2012.483","article-title":"miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer","volume":"32","author":"Su","year":"2013","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104108_bib0018","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/HYPERTENSIONAHA.118.12084","article-title":"GRP78 (glucose-regulated protein of 78 kDa) promotes cardiomyocyte growth through activation of GATA4 (GATA-binding protein 4)","volume":"73","author":"Zhang","year":"2019","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104108_bib0019","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.RES.87.9.731","article-title":"Calcineurin and beyond: cardiac hypertrophic signaling","volume":"87","author":"Molkentin","year":"2000","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104108_bib0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/01.RES.0000109415.17511.18","article-title":"Calcineurin\/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy","volume":"94","author":"Wilkins","year":"2004","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104108_bib0021","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/CIRCRESAHA.109.194035","article-title":"CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes","volume":"105","author":"MacDonnell","year":"2009","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104108_bib0022","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41569-019-0218-x","article-title":"RNA-based diagnostic and therapeutic strategies for cardiovascular disease","volume":"16","author":"Lu","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104108_bib0023","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd4140","article-title":"MicroRNAs and other non-coding RNAs as targets for anticancer drug development","volume":"12","author":"Ling","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"13","key":"10.1016\/j.ebiom.2022.104108_bib0024","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.4155\/fmc.15.107","article-title":"miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart","volume":"7","author":"Bernardo","year":"2015","journal-title":"Future Med Chem"},{"issue":"39","key":"10.1016\/j.ebiom.2022.104108_bib0025","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.2174\/1381612823666170714151715","article-title":"MiRNA-based therapeutics for lung cancer","volume":"23","author":"Wu","year":"2018","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104108_bib0026","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s12265-020-10065-w","article-title":"MicroRNA-151 attenuates apoptosis of endothelial cells induced by oxidized low-density lipoprotein by targeting interleukin-17A (IL-17A)","volume":"14","author":"Chen","year":"2021","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.ebiom.2022.104108_bib0027","article-title":"Exercise attenuates angiotensin-induced muscle atrophy by targeting PPARgamma\/miR-29b","author":"Liu","year":"2021","journal-title":"J Sport Health Sci"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104108_bib0028","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jshs.2020.03.004","article-title":"The roles of microRNA in redox metabolism and exercise-mediated adaptation","volume":"9","author":"Torma","year":"2020","journal-title":"J Sport Health Sci"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104108_bib0029","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.canlet.2015.03.041","article-title":"MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer","volume":"362","author":"Chen","year":"2015","journal-title":"Cancer Lett"},{"issue":"18","key":"10.1016\/j.ebiom.2022.104108_bib0030","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1158\/0008-5472.CAN-17-3058","article-title":"miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes","volume":"78","author":"Croset","year":"2018","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104108_bib0031","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/2211-5463.13025","article-title":"miR-30d-5p suppresses proliferation and autophagy by targeting ATG5 in renal cell carcinoma","volume":"11","author":"Liang","year":"2021","journal-title":"FEBS Open Bio"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104108_bib0032","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00380-021-01853-8","article-title":"Serum microRNA-30d is a sensitive biomarker for angiotensin II-induced cardiovascular complications in rats","volume":"36","author":"Morishima","year":"2021","journal-title":"Heart Vessels"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104108_bib0033","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138027","article-title":"MicroRNA-30 regulates left ventricular hypertrophy in chronic kidney disease","volume":"6","author":"Bao","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.ebiom.2022.104108_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.652224","article-title":"Expression profile of circulating MicroRNAs in dogs with cardiac hypertrophy: a pilot study","volume":"8","author":"Ro","year":"2021","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.ebiom.2022.104108_bib0035","doi-asserted-by":"crossref","first-page":"e1479","DOI":"10.1038\/cddis.2014.430","article-title":"MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy","volume":"5","author":"Li","year":"2014","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104108_bib0036","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12933-022-01458-z","article-title":"MiR-30 promotes fatty acid beta-oxidation and endothelial cell dysfunction and is a circulating biomarker of coronary microvascular dysfunction in pre-clinical models of diabetes","volume":"21","author":"Veitch","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ebiom.2022.104108_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.744509","article-title":"Plasma exosome-enriched extracellular vesicles from lactating mothers with type 1 diabetes contain aberrant levels of miRNAs during the postpartum period","volume":"12","author":"Frorup","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104108_bib0038","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00592-010-0226-0","article-title":"Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study","volume":"48","author":"Kong","year":"2011","journal-title":"Acta Diabetol"},{"issue":"37","key":"10.1016\/j.ebiom.2022.104108_bib0039","doi-asserted-by":"crossref","first-page":"31155","DOI":"10.1074\/jbc.M112.362632","article-title":"MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein 4 kinase 4 (MAP4K4) in pancreatic beta-cells","volume":"287","author":"Zhao","year":"2012","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104108_bib0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1261\/rna.1211209","article-title":"Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription","volume":"15","author":"Tang","year":"2009","journal-title":"RNA"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104108_bib0041","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1159\/000445565","article-title":"Regulation of insulin resistance by multiple MiRNAs via targeting the GLUT4 signalling pathway","volume":"38","author":"Zhou","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.ebiom.2022.104108_bib0042","article-title":"Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy","author":"Phang","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104108_bib0043","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1161\/CIRCRESAHA.121.320458","article-title":"Small extracellular vesicles from brown adipose tissue mediate exercise cardioprotection","volume":"130","author":"Zhao","year":"2022","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104108_bib0044","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/ehf2.12017","article-title":"Six1 is down-regulated in end-stage human dilated cardiomyopathy independently of Ezh2","volume":"1","author":"Tschirner","year":"2014","journal-title":"ESC Heart Fail"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104108_bib0045","doi-asserted-by":"crossref","first-page":"C253","DOI":"10.1152\/ajpcell.00375.2018","article-title":"Inhibition of Smurf2 translation by miR-322\/503 protects from ischemia-reperfusion injury by modulating EZH2\/Akt\/GSK3beta signaling","volume":"317","author":"Dong","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104108_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112059","article-title":"FBXW7 promotes pathological cardiac hypertrophy by targeting EZH2-SIX1 signaling","volume":"393","author":"Gao","year":"2020","journal-title":"Exp Cell Res"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104108_bib0047","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1113\/EP088881","article-title":"Inhibition of EZH2 attenuates coronary heart disease by interacting with microRNA-22 to regulate the TXNIP\/nuclear factor-kappaB pathway","volume":"105","author":"Liu","year":"2020","journal-title":"Exp Physiol"},{"key":"10.1016\/j.ebiom.2022.104108_bib0048","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.yjmcc.2019.08.003","article-title":"EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation","volume":"135","author":"Song","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ebiom.2022.104108_bib0049","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.yjmcc.2020.12.012","article-title":"Elevated EZH2 in ischemic heart disease epigenetically mediates suppression of NaV1.5 expression","volume":"153","author":"Zhao","year":"2021","journal-title":"J Mol Cell Cardiol"},{"issue":"19","key":"10.1016\/j.ebiom.2022.104108_bib0050","doi-asserted-by":"crossref","first-page":"8494","DOI":"10.7150\/thno.44849","article-title":"EZH2-mediated epigenetic silencing of miR-29\/miR-30 targets LOXL4 and contributes to tumorigenesis, metastasis, and immune microenvironment remodeling in breast cancer","volume":"10","author":"Yin","year":"2020","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104108_bib0051","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/path.4294","article-title":"EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesis","volume":"232","author":"Zhang","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.ebiom.2022.104108_bib0052","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainresbull.2020.12.019","article-title":"Knockdown EZH2 attenuates cerebral ischemia-reperfusion injury via regulating microRNA-30d-3p methylation and USP22","volume":"169","author":"Jin","year":"2021","journal-title":"Brain Res Bull"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104108_bib0053","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.stem.2019.01.013","article-title":"MAP4K4 inhibition promotes survival of human stem cell-derived cardiomyocytes and reduces infarct size in vivo","volume":"24","author":"Fiedler","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104108_bib0054","doi-asserted-by":"crossref","first-page":"12060","DOI":"10.1038\/s41598-020-68907-1","article-title":"Selective protection of human cardiomyocytes from anthracycline cardiotoxicity by small molecule inhibitors of MAP4K4","volume":"10","author":"Golforoush","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104108_bib0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00395-021-00875-7","article-title":"Preclinical trial of a MAP4K4 inhibitor to reduce infarct size in the pig: does cardioprotection in human stem cell-derived myocytes predict success in large mammals?","volume":"116","author":"Te Lintel Hekkert","year":"2021","journal-title":"Basic Res Cardiol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422002894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422002894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:15:33Z","timestamp":1762456533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422002894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":55,"alternative-id":["S2352396422002894"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104108","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting miR-30d reverses pathological cardiac hypertrophy","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104108"}}